| Literature DB >> 33457372 |
Marcelo Aveiro1, Gisela Ferreira2, Carla Matias1, Ana Oliveira1, Tatiana Rodrigues1.
Abstract
Autoimmune haemolytic anaemia (AIHA) is an uncommon condition characterized by increased destruction of erythrocytes associated with reticulocytosis in the great majority of cases. We present the case of a 68-year-old woman with jaundice and malaise. Investigation revealed AIHA with reticulocytopenia. The patient failed to respond to prednisolone or to rituximab. Azathioprine and epoetin beta were subsequently started, the prednisolone dose was increased, and the patient began to respond after 1 month. In AIHA, reticulocytopenia is a very rare presentation and a sign of great severity and poor outcome. The scarcity of therapeutic options in refractory cases poses a major challenge for physicians. LEARNING POINTS: Autoimmune haemolytic anaemia is a rare disorder characterized by decompensated acquired haemolysis caused by the host's immune system acting against its own red cell antigens.Concomitant presentation with reticulocytopenia is very rare and a sign of great severity and poor outcome.Treatment options in refractory cases still greatly rely on individual experience and expert opinion. © EFIM 2020.Entities:
Keywords: Haemolytic anaemia; azathioprine; reticulocytopenia
Year: 2020 PMID: 33457372 PMCID: PMC7806294 DOI: 10.12890/2020_002112
Source DB: PubMed Journal: Eur J Case Rep Intern Med ISSN: 2284-2594